GDUFA: Will Industry Self-Identification Push Lengthen The Backlog?
This article was originally published in The Pink Sheet Daily
Executive Summary
Facility list generated by industry submission likely will include plants that need to be inspected, potentially creating a larger backlog for FDA to clear, but GPhA expects remaining generic drug user fees should be announced by the Jan. 14 deadline.